| Identification | Back Directory | [Name]
Butanoic acid, 4-[2-[[2,3-dimethyl-4-[(1S)-1-[4-(2-methylpropyl)phenyl]ethoxy]benzoyl]amino]phenoxy]-, sodium salt (1:1) | [CAS]
119347-91-0 | [Synonyms]
Ono3805
Ono-3805
Ono 3805
Ono-3805 sodium
Butanoic acid, 4-[2-[[2,3-dimethyl-4-[(1S)-1-[4-(2-methylpropyl)phenyl]ethoxy]benzoyl]amino]phenoxy]-, sodium salt (1:1) | [Molecular Formula]
C31H38NNaO5 | [MDL Number]
MFCD00903892 | [MOL File]
119347-91-0.mol | [Molecular Weight]
527.64 |
| Hazard Information | Back Directory | [Description]
Ono-3805 is a nonsteroidal 5 alpha-reductase inhibitor. | [Uses]
ONO-3805 is an early lead compound of a non-steroidal 5α-reductase inhibitor, used to inhibit the conversion of testosterone to dihydrotestosterone, with potential effects in inhibiting benign prostatic hyperplasia. | [References]
[1] Expedient Pd‐Catalyzed α‐Arylation towards Dibenzoxepinones: Pivotal Manske's Ketone for the Formal Synthesis of Cularine Alkaloids |
|
|